Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

celgene_1_02

Celgene and Agios to file FDA application for “first-in-class” cancer drug

September 8, 2016 Research and Development, Sales and Marketing Celgene, FDA, NDA, acute myeloid leukaemia, agios

According to an SEC 8-K filing by Agios, the company and its partner Celgene intend to file a new drug …
News
takeda_tokyo_hq

Takeda begins Phase III dengue vaccine trial

September 8, 2016 Research and Development Takeda, Vaccine, dengue, dengue vaccine, phase III, trial

Takeda Pharmaceuticals has announced the initiation of a global Phase III clinical trial to test its live-attenuated tetravalent dengue vaccine …
News
c_ssilver-fotolia_ebr_jul_2014

Clinical Trial Transparency

September 8, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trial, clinical trial transparency, transparency

Amid the global political and economic turmoil taking place, one small pharma story got much less attention than it should …
Feature
merck_and_co

FDA to review MSD’s Keytruda as a first-line lung cancer treatment

September 7, 2016 Research and Development FDA, MSD, Merck, first-line, keytruda, lung cancer, non-small cell lung cancer, opdivo

The US Food and Drug Administration has accepted the supplemental biologics license application from MSD, known as Merck in the …
News
ole_isacson

Pfizer appoints new chief scientific officer for neuroscience research

September 7, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Ole Isacson has been named as the chief scientific officer at Pfizer’s neuroscience research unit. He will continue to …
Appointment
brent_saunders

Allergan CEO outlines ‘social contract with patients’

September 7, 2016 Research and Development, Sales and Marketing Allergan, Brent Saunders, CEO, blog

Highlighting a recent shift in the priorities of the pharmaceutical industry, Allergan CEO and president Brent Saunders has outlined a …
News
clinical_trial_4

Tonix tanks after Phase III failure

September 7, 2016 Research and Development PTSD, fibromylagia, phase III failure, tonix, tonix pharmaceuticals

New York-based Tonix Pharmaceuticals has suffered an almost 60% fall in their share price, after the announcement that its fibromyalgia …
News
allergan

Allergan acquires biotech Retrosense for $60 million

September 7, 2016 Research and Development, Sales and Marketing Allergan, Retrosense, acquisition

Allergan has announced that it has acquired Retrosense, a biotech focused on novel gene therapy approaches to restore vision in …
News
legal

Antitrust investigation launched into Mylan and the EpiPen scandal

September 7, 2016 Research and Development, Sales and Marketing Mylan, US, antitrust, epipen, investigation, lawmakers, scandal

The New York attorney general has commenced an investigation into Mylan Pharmaceuticals, after an initial review indicated that the company …
News
bms

European Commission approves new RA treatment from BMS

September 6, 2016 Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, EMA, EU, Orencia, RA, abatacept, approval, rheumatoid arthritis

Bristol-Myers Squibb has received approval from the European Commission for rheumatoid arthritis (RA) treatment Orencia (abatacept), making it the first …
News
iqwigsmall

Eisai “cannot understand” German agency’s recommendation to reject Halaven

September 6, 2016 Manufacturing and Production, Research and Development Eisai, Germany, Halaven, IQWIG, german

Eisai has issued a statement to declare their “bewilderment” following a decision from the German Institute for Quality and Efficiency …
News
shutterstock_123182704

Horizon and Fulcrum Therapeutics form CRISPR collaboration

September 6, 2016 Manufacturing and Production, Research and Development Horizon Discovery, crispr, fulcrum, fulcrum therapeutics, gene editing, horizon, rare diseases

Horizon Discovery has announced that it has entered into a partnership with Fulcrum Therapeutics to utilise Horizon’s CRISPR-based screening platform …
News
shutterstock_291014192

Non-invasive ventilation touted for COPD treatment at respiratory meeting

September 6, 2016 Manufacturing and Production, Research and Development COPD, resmed

ResMed has presented results at the European Respiratory Society international congress, touting home non-invasive ventilation (NIV) as part of a …
News
rd_hands

Takeda secures $312 million zika vaccine development contract

September 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Takeda, US government, Zika, world health organization

Takeda has announced that it has been granted a $312 million contract from the US government to develop an inactivated, …
News
gsk_boronia_australia

GSK announce positive results for chronic obstructive pulmonary disease treatment

September 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing GlaxoSmithKline, Innoviva, Revlar Ellipta, chronic obstructive pulmonary disease

GlaxoSmithKline and its partner Innoviva have announced that its Relvar Ellipta achieved positive results in its COPD Salford lung study …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025